期刊文献+

流感病毒在Vero细胞上的增殖 被引量:4

Proliferation of Influenza Viruses in Vero Cells
下载PDF
导出
摘要 目的研究流感病毒在非洲绿猴肾细胞(Vero细胞)上高效增殖的最适条件。方法将Vero细胞在50cm2细胞瓶或3000mL旋转瓶中培养成单层,以不同感染复数接种流感病毒,在不同的培养条件下孵育,取上清测病毒血凝滴度。结果当加入胰酶终浓度为40μg·mL-1时,低感染复数接种流感病毒,可获得高效价病毒液,在3000mL旋转培养瓶中流感病毒的易感性较在50cm2静置培养瓶中略高。结论建立了流感病毒在Vero细胞上高效增殖的初步方法。 To study condition of influenza viruse proliferating with high virus yields in Vero cells, Vero cells were propagated as monolayers in 50cm 2 flasks or in 3000ml rolling bottles、The inoculated influenza viruses at different multiplicities of infection(MOI) and incubated in the different pH conditions and different doses of trypsin. The virus yields were determinated by hemagglutination(HA) assay at different time. The high virus yields were able to be obtained with low MOI when the final concentration of trypsin was 40μg·ml -, The susceptibility of influenza viruses to Vero cells propagated as monolayers in 3000ml rolling bottles was higher than in 50cm 2 flasks. The procedure for influenza viruses proliferating with high virus yields has been established。
出处 《氨基酸和生物资源》 CAS 2004年第4期56-58,共3页 Amino Acids & Biotic Resources
关键词 流感病毒 VERO细胞 增殖条件 疫苗 宿主细胞 influenza virus Vero cell
  • 相关文献

参考文献6

  • 1郭元吉,程小雯.流行性感冒病毒及其实验技术.北京:中国三峡出版社,1997.
  • 2Kistner O, Barrett PN, Mundt W, et al. Development of a mammalian cell (Vero) derived cadidate influenza virus vaccine. [J]Vaccine, 1998,16: 960~968.
  • 3Kaverin NV, Webster RG,Impairment of multicycle influenza virus growth in Vero (WHO) cells by loss of trypsin activity. [J] J of Virology. 1995,69:2700~2703.
  • 4Otfried Kistner, Noel Barret P, Wolfgang Mundt, et al. A novel mammalian cell (Vero) derived influenza virus vaccine: Development, characterization and industial scale production. [J] Wien klim wochenscher. 1999,111:207~214.
  • 5Halperin SA, Nestruck AC, Eastwood BJ. Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture. [J] Vaccine 1998 Aug; 16(13): 1331~1335.
  • 6Percheson PB, Trepanier P, Dugre R, et al. A phase I, randomized controlled clinical trial to study the reactogenicity an immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line. [J] Dev Biol Stand 1999: 98: 127~132.

同被引文献39

引证文献4

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部